Bilcare Research investment in European production of Aclar® laminates
The new investment marks a significant milestone in offering truly integrated solutions and supply chain advantages for the global pharmaceutical industry. It will allow Bilcare to offer best in class delivery of Aclar® laminates for stability packaging, line trial samples as well as full commercial volumes.
Bilcare's range of Aclar® laminates provides the highest moisture barrier of any films of its type and are crystal clear, biochemically inert, chemical-resistant, non-flammable and plasticizer- as well as stabilizer-free.
"This investment in our new laminating line is the latest component of our continued growth strategy to meet the needs of the rapidly evolving business models of the global pharmaceutical industry. We see increased demand across our entire range of Bilcare Aclar® laminates, from both innovator and generic pharmaceutical companies", commented Thorsten Kühn, CEO of Bilcare Research AG, Switzerland.
Bilcare Research GmbH
Bilcare Solutions (www.bilcaresolutions.com) is alongside with the businesses Global Clinical Supplies und Bilcare Technologies part of the Bilcare Research Group (www.bilcare.com) which operates 13 sites with 2,300 employees worldwide. Bilcare Solutions is a global producer of rigid films. Its manufacturing and marketing activity is concentrated in the production of rigid PVC and PVC/PE films and includes the finishing of films in the form of coating, stentering, laminating and metallizing. The company is also involved in the extrusion of PET-films. With over 50 years experience in the production of rigid films, Bilcare Solutions today is one of the leading rigid film producers in the world. Worldwide the company employs approximately 1,300 people with sites in Germany, Italy, India, Singapore, UK and USA. It has the capacity to produce around 130,000 tonnes of films per annum and had sales of EUR 300 million in 2011.